Patients with myeloproliferative neoplasms have an increased risk of thrombosis and bleeding. This risk must be identified, as well as individualizing the therapeutic strategy before invasive procedures; adequate cytoreduction reduces the risk of complications.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.24875/GMM.M22000808 | DOI Listing |
Publication Analysis
Top Keywords
invasive procedures
8
risks invasive
4
procedures patients
4
patients myeloproliferative
4
myeloproliferative neoplasms
4
neoplasms increased
4
increased risk
4
risk thrombosis
4
thrombosis bleeding
4
bleeding risk
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!